China grants its highest-ever antitrust damages award

A court in Nanjing has awarded Yangtze River Pharmaceutical Group nearly €9 million for successfully showing that suppliers of an active pharmaceutical ingredient for its antihistamine tablet abused their dominance.


Get unlimited access to all Global Competition Review content